Kaletra - direct healthcare professional communication (DHPC)

lopinavir / ritonavir

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Kaletra (lopinavir/ritonavir) oral solution, 2 bottle pack containing 2-ml oral dosing syringes: Presence of amide particles in 2-ml oral dosing syringes

Key facts

• Medicine name:
  Kaletra
• Active substance:
  • lopinavir
  • ritonavir
• Therapeutic area (MeSH):
  HIV Infections
• Procedure number:
  EMEA/H/C/000368
• DHPC type:
  Quality defect
• Dissemination date:
  23/12/2020